Bede, Peter http://orcid.org/0000-0003-0492-4772
Omer, Taha
Finegan, Eoin
Chipika, Rangariroyashe H.
Iyer, Parameswaran M.
Doherty, Mark A.
Vajda, Alice
Pender, Niall
McLaughlin, Russell L.
Hutchinson, Siobhan
Hardiman, Orla
Funding for this research was provided by:
Health Research Board (HRB EIA-2017-019)
Irish Institute of Clinical Neuroscience − Novartis Ireland Research Grant (IICN 2016)
Iris O’Brien Foundation (2016)
Perrigo Clinician-Scientist Research Fellowship (2016)
Research Motor Neuron (RMN-Ireland) Foundation (2015)
Article History
First Online: 8 February 2018
Compliance with ethical standards
:
: Peter Bede declares that he has no conflict of interest. Taha Omer declares that he has no conflict of interest. Eoin Finegan declares that he has no conflict of interest. Rangariroyashe H. Chipika declares that she has no conflict of interest. Parameswaran M. Iyer declares that he has no conflict of interest. Mark A. Doherty declares that he has no conflict of interest. Alice Vajda declares that she has no conflict of interest. Niall Pender declares that he has no conflict of interest. Russell L. McLaughlin declares that he has no conflict of interest. Siobhan Hutchinson declares that she has no conflict of interest. Orla Hardiman has received speaking honoraria from Janssen Cilag, Biogen Idec, Sanofi Aventis and Merck-Serono, she has been a member of advisory panels for Biogen Idec, Allergen, Cytokinetics, Ono Pharmaceuticals and Sanofi Aventis.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional (Ethics (Medical Research) Committee - Beaumont Hospital, Dublin, Ireland) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.